The analysis indeed showed significantly induced SPRR1A, KRAS, p53 in cerulein-with-AOM–treated mice compared with the control groups of mice, including cerulein-treated mice (Fig 4A and B). This evidence concerns the gene TP53 and infectious otitis media.